Home NDC 63833-838 NDC 63833-838 - HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human) This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 63833-838
Package NDCs from labels 63833-838-01
Manufacturer CSL Behring GmbH
Effective date 2022-02-04
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63833-838-01 HAEGARDAC1 Esterase Inhibitor Subcutaneous (Human) 4 mL in 1 VIAL, SINGLE-USE INJECTION, POWDER, FOR SOLUTION 4 mL 2000 [iU] in 4mL 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63833-838 HAEGARDA C1 ESTERASE INHIBITOR SUBCUTANEOUS (HUMAN) (HUMAN C1-ESTERASE INHIBITOR) KIT [CSL BEHRING GMBH] 8 Unmatched 20220831_e270ad38-adc4-4ed5-88e3-943b93d20a57.zip